Literature DB >> 23378545

Delayed cerebritis after bilateral stereotactic implantation of globus pallidus interna electrodes for treatment of dystonia.

Pawel P Jankowski1, Stephanie Lessig, Andrew D Nguyen, David Barba.   

Abstract

Deep brain stimulation (DBS) is being used to treat an increasing number of movement and psychiatric disorders. However, the risk of infection remains as a problem that can hinder the usefulness of this technology. We report a case of a patient with dystonia who underwent bilateral globus pallidus interna electrode and impulse generator (IPG) placement, developed an infection of his IPG, and later cerebritis. The patient was initially treated with antibiotics and partial hardware removal. Follow-up cranial imaging showed an area concerning for cerebritis around one of the intracranial electrodes. The patient was then treated with complete hardware removal followed by a course of intravenous antibiotics. Four-month follow-up imaging showed resolution of the infection. This case demonstrates the importance of following cranial imaging in DBS patients with delayed infection, continued vigilance for infection in implanted patients and that partial hardware removal may not be successful in the setting of methicillin-sensitive Staphylococcus aureus infections.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23378545      PMCID: PMC3603542          DOI: 10.1136/bcr-2012-006934

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  21 in total

1.  Hardware-related complications of deep brain stimulation: a ten year experience.

Authors:  P Blomstedt; M I Hariz
Journal:  Acta Neurochir (Wien)       Date:  2005-07-25       Impact factor: 2.216

Review 2.  Infections and hardware salvage after deep brain stimulation surgery: a single-center study and review of the literature.

Authors:  Sanjay Bhatia; Kai Zhang; Michael Oh; Cindy Angle; Donald Whiting
Journal:  Stereotact Funct Neurosurg       Date:  2010-04-01       Impact factor: 1.875

3.  Reducing hardware-related complications of deep brain stimulation.

Authors:  Constantine Constantoyannis; Caglar Berk; Christopher R Honey; Ivar Mendez; Robert M Brownstone
Journal:  Can J Neurol Sci       Date:  2005-05       Impact factor: 2.104

4.  Deep-brain stimulation: long-term analysis of complications caused by hardware and surgery--experiences from a single centre.

Authors:  J Voges; Y Waerzeggers; M Maarouf; R Lehrke; A Koulousakis; D Lenartz; V Sturm
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03-30       Impact factor: 10.154

5.  Multicentre European study of thalamic stimulation in parkinsonian and essential tremor.

Authors:  P Limousin; J D Speelman; F Gielen; M Janssens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-03       Impact factor: 10.154

Review 6.  Treatment of chronic pain by deep brain stimulation: long term follow-up and review of the literature.

Authors:  R M Levy; S Lamb; J E Adams
Journal:  Neurosurgery       Date:  1987-12       Impact factor: 4.654

7.  A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor.

Authors:  P R Schuurman; D A Bosch; P M Bossuyt; G J Bonsel; E J van Someren; R M de Bie; M P Merkus; J D Speelman
Journal:  N Engl J Med       Date:  2000-02-17       Impact factor: 91.245

Review 8.  Deep brain stimulation for intractable pain: a 15-year experience.

Authors:  K Kumar; C Toth; R K Nath
Journal:  Neurosurgery       Date:  1997-04       Impact factor: 4.654

Review 9.  Deep brain stimulation hardware-related infections: a report of 12 cases and review of the literature.

Authors:  Fabien Fily; Claire Haegelen; Pierre Tattevin; Sylvie Buffet-Bataillon; Matthieu Revest; Anne Cady; Christian Michelet
Journal:  Clin Infect Dis       Date:  2011-04-15       Impact factor: 9.079

10.  Deep brain stimulator hardware-related infections: incidence and management in a large series.

Authors:  Karl A Sillay; Paul S Larson; Philip A Starr
Journal:  Neurosurgery       Date:  2008-02       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.